Get your weekly dose of everything in the news about incretin mimetic therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!
Dave Knapp Man On The Mounjaro
Donate to On The Pen: The Weekly Dose
The On The Pen: The Weekly Dose podcast is a fantastic addition to Dave's repertoire of content. As someone who follows him on Instagram but prefers a podcast format, I was thrilled when he announced the launch of this show. It provides the perfect opportunity for me to stay informed and entertained while I'm driving or cleaning. Right from the first episode, it is evident that the production quality is top-notch. The sound is crisp and clear, making for an enjoyable listening experience. Additionally, the inclusion of hyperlinks in the episode notes is greatly appreciated as it allows me to easily access additional resources mentioned during the show.
One of the best aspects of The On The Pen podcast is Dave's ability to simplify complex concepts related to healthcare and make them accessible to anyone. In a field that can often be overwhelming with intricate details, he does an excellent job of breaking down information so that even those without a medical background can understand it. This approach makes his content valuable to a wide range of listeners who are seeking knowledge and empowerment.
Another commendable aspect of this podcast is Dave's fair and unbiased reporting. While there are often controversial topics in healthcare, he remains neutral and presents information objectively. This allows listeners to form their own opinions based on facts rather than feeling swayed by personal biases or agendas.
While it's challenging to find any major flaws in this podcast, one minor criticism would be that some episodes may not cater specifically to individual interests or needs. However, given the variety of topics covered in each episode, it is understandable that not every segment will resonate with every listener. Nevertheless, Dave's engaging style and ability to deliver information effectively compensate for any potential lack of interest in specific topics.
In conclusion, The On The Pen: The Weekly Dose podcast is a must-listen for anyone looking for accessible and informative healthcare content. Dave's dedication to keeping his audience updated with accurate facts while maintaining an engaging delivery style sets this podcast apart. I highly recommend jumping on board early to join the ever-growing community of listeners who appreciate the valuable knowledge and motivation that Dave delivers.
VISIT OUR LINKS: https://linktr.ee/manonthemounjaro
Visit Our Links: https://linktr.ee/manonthemounjaro
VISIT ALL OUR LINKS: https://linktr.ee/manonthemounjaro
Visit Our Links: https://linktr.ee/manonthemounjaro
All Our Links: https://linktr.ee/manonthemounjaro Obesity Newsletter: https://www.obesity.news https://onthepen.substack.com/p/stunning-news-zepbound-shrinks-breast https://onthepen.substack.com/p/semaglutide-risk-recent-iowa-study
All Referenced Links: https://linktr.ee/manonthemounjaro
This week, Dave covers massive GLP-1 news out of Connecticut, a new GLP-1 heart study that changes the conversation, and a big OTP event opportunity announcement!
https://www.getclaimable.com/otp Code OTP10 Saves 10% Get Our Newsletter and Help us Grow! https://www.obesity.news Support OTP (all our links): https://linktr.ee/manonthemounjaro
Get Our Newsletter and Help us Grow! https://www.obesity.news Support OTP (all our links): https://linktr.ee/manonthemounjaro
https://www.getclaimable.com/otp Code OTP10 Saves 10% Get Our Newsletter and Help us Grow! https://www.obesity.news Support OTP (all our links): https://linktr.ee/manonthemounjaro #zepbound #insurance #cvscaremark
Get Our Newsletter and Help us Grow! https://www.obesity.news Support OTP (all our links): https://linktr.ee/manonthemounjaro
At 650 pounds, GLP-1 injections helped give Jamie His Life Back. Get Our Newsletter and Help us Grow! https://www.obesity.news Support OTP (all our links): https://linktr.ee/manonthemounjaro
SUPPORT OUR WORK AND GET MORE NEWS! https://linktr.ee/manonthemounjaro
https://www.linktr.ee/manonthemounjaro Ozempic rare eye disease update The the race for once monthly dosing Big insurance wins incoming?!
VIEW ALL OF OUR LINKS: https://linktr.ee/manonthemounjaro JOIN OUR SUBSTACK: HTTP://WWW.ONTHEPEN.SUBSTACK.COM
Join the Substack here: onthepen.substack.com Get all my links here: https://linktr.ee/manonthemounjaro
Joe's Petition + All My Links: https://linktr.ee/manonthemounjaro
Dave discussed the latest update in the OFA vs FDA compound tirzepatide battle, as well as this weeks news in obesity medicine. Find our substack and all promotional links here: https://linktr.ee/manonthemounjaro
CVS announces major partnership with Novo Nordisk as Lilly announces Q! 2025 earnings. Dave covers it all in today's breakdown. Join the Substack: https://substack.com/@onthepen WAYS TO SUPPORT MY WORK ⬇️
Join the Substack: https://substack.com/@onthepen WAYS TO SUPPORT MY WORK ⬇️
WAYS TO SUPPORT MY WORK ⬇️
The Knapp family was featured in a health.com video! Watch it Here: https://www.health.com/beyond-obesity-glp1-8685599 WAYS TO SUPPORT MY WORK ⬇️
The Knapp family was featured in a health.com video! Watch it Here: https://www.health.com/beyond-obesity-glp1-8685599 WAYS TO SUPPORT MY WORK ⬇️
The Knapp family was featured in a health.com video! Watch it Here: https://www.health.com/beyond-obesity-glp1-8685599 WAYS TO SUPPORT MY WORK ⬇️
WAYS TO SUPPORT MY WORK ⬇️
WAYS TO SUPPORT MY WORK ⬇️
Ozempic, Trulicity and Victoza are decreasing dementia by 45%, so what is going on with Medicare coverage for obesity medicine? The Knapp family was featured in a health.com video! Watch it Here: https://www.health.com/beyond-obesity-glp1-8685599 WAYS TO SUPPORT MY WORK ⬇️
Dave sits down with a favorite OTP guest, Dr. Spencer Nadolsky of the Docs Who Lift Podcast to discuss a recent study that asked, “Does Sucralose Increase Hunger?” Dr. Spencer gives his take. Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
In this rare and exclusive interview, the chairman of the Outsourcing Facilities Association sits down with On The Pen to discuss the current landscape of compound tirzepatide. Www.503bs.org
Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
's course, use code “OTP20” to save 20%! https://www.drtyna.com/offers/VstUywXc/checkout Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
Dave discusses the latest in the compound tirzepatide legal battles, cagrisema delivers more big let downs, and some exciting news about VK2735 aka Vikingtide Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
Dr. Catherine Harmon Toomer is a board certified Family Medicine physician, certified hypnotherapist & NLP practitioner, founder of TOTAL Weight Care Institute™️ and Your Light Wellness & Weight Care Group. She provides comprehensive and compassionate alternative to the shame-to-change model & yo-yo progress too often experienced in wellness and weight health spaces. Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
The latest in compounded semaglutide and tirzepatide, as well as the meaning behind World Obesity Day Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
GLP-1 community builder Mike Donnelly-Boylen joins Dave to discuss his health mission and experience losing 100 pounds with Mounjaro! Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
Lilly releases higher dose Zepbound vials, reduces price for patients paying out of pocket. Meanwhile, the tirzepatide lawsuit heats up, with a potential ruing on preliminary injunction. The OFA strikes up a new battle with the FDA, suing them now over the end of the semaglutide shortage. Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
OTP legal expert Lee Thomas joins to discuss the latest in the compound Tirzepatide lawsuit. Dr Simin Lee joins Dave to discuss obesity, GLP-1 medications and heart health! Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
On the 101st episode of On The Pen Live, Dave discusses this week's news in GLP-1, we get weight loss maintenance tips from Korrie, and a Reddit recap from @FitFlavorFun ! For the interview portion, Dave welcomes Charles aka @RoundMoundofZepbound to discuss his health story as well as dealing with a cancer diagnosis after Zepbound weight loss. Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
Breaking Compound Tirzepatide News Lilly announces next generation of GLP-1 / GIP med Trump advocates for cheaper "Fat Shot" HIMS faces industry scrutiny Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
In the 100th episode of On The Pen Live, BJ Davis shares his inspiring 158 lb weight loss journey using Mounjaro, revealing how GLP-1 medications, exercise, and lifestyle changes transformed his life. With insights into the power of community support and expert advice, this milestone episode is a must-listen for anyone interested in sustainable weight loss and the role of GLP-1s in long-term health success! First Episode with BJ: https://www.youtube.com/live/ZrTZGwbNW98 Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
Dave Knapp breaks down what the Q4 Eli Lilly earnings call means for patients living with obesity. https://www.onthepen.com/post/lilly-s-earnings-call-could-reveal-big-changes-for-zepbound-retatrutide-what-they-ve-said-and-wha Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
From high dose semaglutide to cagrisema launch dates, Dave Knapp discusses how the latest Novo Nordisk earnings call impacts patients. Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
Dave covers this week's news in GLP-1 and anti-obesity medicine news. #RETATRUTIDE #ENOBARSARM #zepbound Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
Jamie has lost 463 pounds combining #Ozempic then #Mounjaro #Tirzepatide and Weight Loss Surgery. Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
Lilly to offer higher doses of #Zepbound for less money? New obesity definition High dose #Wegovy trial data APC releases FDA info on enforcement of compounded #tirzepatide Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
© 2020-2025 Ivy Podcast Discovery LLC
